ALTÉRATIONS MÉTABOLIQUES ET GÉNÉTIQUES DES CANCERS COLORECTAUX ET APPROCHES THÉRAPEUTIQUES. Potentialisation de l'effet des inhibiteurs de la thymidylate synthétase par des analogues du butyrate et effet différentiel antitumoral de l'irinotécan, inhibiteur de topoisomérase I sur des modèles de cancers colorectaux humains transplantables sur souris nude = METABOLIC AND GENETIC IMBALANCES IN COLORECTAL CANCER AND THERAPEUTIC APPROACHES Synergistic Efficacy of Stable Butyrate Analogs and Thymidylate Synthase Inhibitors in Human Colorectal Cancer Xenografts and Differential Antitumoral Effects of Irinotecan, a Topoisomerase I Inhibitor, on Human Colorectal Cancer Models Xenografted into nude MiceBras Gonçalves, Rui Alberto; Poupon, Marie-France.2000, 277 p.Thesis

Single alteration of p53 or E-cadherin genes can alter the Surgical resection benefit in an experimental model of colon cancerPOCARD, Marc; DEBRUYNE, Philip; BRAS-GONCALVES, Rui et al.Diseases of the colon & rectum. 2001, Vol 44, Num 8, pp 1106-1112, issn 0012-3706Conference Paper

Activity of docetaxel with or without estramustine phosphate versus mitoxantrone in androgen dependent and independent human prostate cancer xenograftsOUDARD, Stephane; LEGRIER, Marie-Emmanuelle; BOYE, Karine et al.The Journal of urology. 2003, Vol 169, Num 5, pp 1729-1734, issn 0022-5347, 6 p.Article

Topoisomerase I-DNA covalent complexes in human colorectal cancer xenografts with different p53 and microsatellite instability status : Relation with their sensitivity to CTP-11LANSIAUX, Amelie; BRAS-GONCALVES, Rui A; ROSTY, Christophe et al.Anticancer research. 2001, Vol 21, Num 1A, pp 471-476, issn 0250-7005Article

Clinical and experimental progression of a new model of human prostate cancer and therapeutic approachDE PINIEUX, Gonzague; LEGRIER, Marie-Emmanuelle; JUNIEN, Jean-Louis et al.The American journal of pathology. 2001, Vol 159, Num 2, pp 753-764, issn 0002-9440Article

Enhanced sensitivity to irinotecan by Cdk1 inhibition in the p53-deficient HT29 human colon cancer cell lineABAL, Miguel; BRAS-GONCALVES, Rui; JUDDE, Jean-Gabriel et al.Oncogene (Basingstoke). 2004, Vol 23, Num 9, pp 1737-1744, issn 0950-9232, 8 p.Article

Gefitinib and chemotherapy combination studies in five novel human non small cell lung cancer xenografts. Evidence linking EGFR signaling to gefitinib antitumor responseJUDDE, Jean-Gabriel; REBUCCI, Magali; BRAS-GONCALVES, Rui-Alberto et al.International journal of cancer. 2007, Vol 120, Num 7, pp 1579-1590, issn 0020-7136, 12 p.Article